Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study
- 30 September 2010
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 32 (10), 1713-1719
- https://doi.org/10.1016/j.clinthera.2010.09.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid ConsumptionAntimicrobial Agents and Chemotherapy, 2008
- Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus BacteremiaClinical Infectious Diseases, 2008
- Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia–Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003–2004)International Journal of Antimicrobial Agents, 2007
- Comparison of Mortality Associated with Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bloodstream Infections: A Meta-analysisClinical Infectious Diseases, 2005
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infectionsJournal of Antimicrobial Chemotherapy, 2004
- Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use ProgramClinical Infectious Diseases, 2003
- Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/DalfopristinClinical Infectious Diseases, 2001
- In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant StrainsAntimicrobial Agents and Chemotherapy, 2000
- The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faeciumJournal of Antimicrobial Chemotherapy, 1999